| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT07218666 | Zanzalintinib in Men With Aggressive Variant Prostate Cancer | Aggressive Variant Prostate Carcinoma | Recruiting |
| NCT04289779 | Study of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr Cancer | Bladder Cancer | Active, Not Recruiting |